Ocular Therapeutix Inc. (OCUL)
OCUL trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$7.24
-4.23% on the day
Market cap
$1.6B
Small cap
Revenue · 2025
$52.0M
-18.5% on 2024
Net income · 2025
-$265.9M
-511.9% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.
Profile
| Field | Value |
|---|---|
| Ticker | OCUL on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | United States |
| IPO year | 2014 |
| SEC CIK | 0001393434 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | DE |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $52.0M |
| Net income | -$265.9M |
| Operating income | -$270.0M |
| Net margin | -511.9% |
| Operating margin | -519.8% |
| Revenue growth | -18.5% |
| Cash | $737.1M |
| Total assets | $808.1M |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 30.6× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B5 | 2025-09-30 |
| Latest annual report | 10-K | 2026-02-05 |
| Latest quarterly / interim | 10-Q | 2026-08-03 |
| Latest current report FORM 8-K | 8-K | 2026-08-03 |
| Latest proxy | DEFA14A | 2026-04-30 |
Source: SEC EDGAR submissions feed, 863 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | -0.6% |
| 1 month | -29.5% |
| 3 months | -21.6% |
| Year to date | -40.8% |
| 1 year | -39.4% |
| From 52-week high | -55.4% |
Source: Yahoo Finance daily closes, last bar 2026-10-14. Computed by Sophia Capital from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| GPCR | Structure Therapeutics Inc. | $22.31 | -6.69% | $1.6B |
| GENB | Generate Biomedicines Inc. | $12.26 | -11.45% | $1.6B |
| ANIP | ANI Pharmaceuticals Inc. | $70.84 | -3.74% | $1.6B |
| CMPS | COMPASS Pathways Plc American Depository Shares | $11.14 | -3.38% | $1.5B |
| ZBIO | Zenas BioPharma Inc. | $25.16 | -4.70% | $1.6B |
| NUVB | Nuvation Bio Inc. | $4.72 | -3.67% | $1.7B |
| ETON | Eton Pharmaceuticals Inc. | $53.33 | -3.48% | $1.5B |
| INVA | Innoviva Inc. | $20.74 | -3.31% | $1.5B |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier